Global Custom Antibody Market projected to be worth USD 889.6 million by 2030.
According to SPER Market Research, the Custom Antibody Market estimated to reach USD 889.6 million by 2030 with a CAGR of 9.4%.
Increasing industry-academia collaborations, growing research activity particularly in the life sciences industry; are the key that impel the market expansion.
Impact of COVID-19 on the Custom Antibody Market
Increase in research activities, availability of funding for research and the demand for antibodies, pharmaceutical companies, and small start-ups, has taken step to develop treatments and vaccines that target the infection. So there is a positive impact in this custom antibody market.
Scope of the report:
Market size available for years 2019-2030
Base year considered 2021
Forecast period 2022-2030
Segments covered By Type, By Service, By Source, By Research Area, By End-User, By Region
Geographies covered North America, Europe, Asia Pacific, Latin America, Middle East, Africa
Companies Covered BioLegend, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., GenScript, Merck Group, Rockland Immunochemicals, Thermo Fisher Scientific, Inc.
Driver: growing research activities and funding
Growing research activities and funding, quality concerns over catalogue antibodies, increasing industry-academia collaborations, rising focus on therapeutic antibodies and extensive pipeline drugs; are the key factors that drive the market expansion.
Restraint:
Antibody development is a costly and time consuming process that resists the market expansion.
Opportunity: Increasing demand for personalized medicine in protein therapeutics
Growing demand for personalized medicine in protein therapeutics, rising focus on biomarker discovery, high growth opportunities in developing countries.
Challenges: Presence of Alternative Antibodies
Availability of alternative antibodies in the market that is a challenge to the custom antibody market expansion.
Global Custom Antibody Market, By Type:
Based on the Type, Global Custom Antibody Market is segmented as; Monoclonal Antibodies, Other Custom Antibodies, Polyclonal Antibodies, Recombinant Antibodies.
Global Custom Antibody Market, By Service:
Based on the Service, Global Custom Antibody Market is segmented as; Antibody Development, Antibody Production & Purification, Antibody Fragmentation & Labeling.
Global Custom Antibody Market, By Source:
Based on the Source, Global Custom Antibody Market is segmented as; Mice, Rabbits, Other Sources.
Global Custom Antibody Market, By Research Area:
Based on the Research Area, Global Custom Antibody Market is segmented as; Cardiovascular Disease, Immunology, Infectious Diseases, Neurobiology, Oncology, Other Research Areas, Stem Cells.
Global Custom Antibody Market, By End-User:
Based on the End-User, Global Custom Antibody Market is segmented as; Academic & Research Institutes, Contract Research organizations, Pharmaceutical & Biotechnology Companies.
Global Custom Antibody Market, By Region:
North America owns the biggest share of the Global Custom Antibody Market; this is because of increasing research in the fields of genomics and proteomics, antibody-based therapeutics. The growing investments in the development of structure-based drug designs, and growing demand for high-quality research tools for data reproducibility.
'
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1 Research data source
2.1.1 Secondary data
2.1.2 Primary data
2.1.3 SPER’s internal database
2.1.4 Premium insight from KOL’s
2.2 Market size estimation
2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2. COVID-19 Impacts of the Custom Antibody Market
5. Market variables and outlook
5.1. SWOT analysis
5.1.1 Strengths
5.1.2 Weaknesses
5.1.3 Opportunities
5.1.4 Threats
5.2. PESTEL analysis
5.2.1 Political landscape
5.2.2 Economic landscape
5.2.3 Social landscape
5.2.4 Technological landscape
5.2.5 Environmental landscape
5.2.6 Legal landscape
5.3. PORTER’S five forces analysis
5.3.1 Bargaining power of suppliers
5.3.2 Bargaining power of Buyers
5.3.3 Threat of Substitute
5.3.4 Threat of new entrant
5.3.5 Competitive rivalry
5.4. Heat map analysis
6. Global Custom Antibody Market, By Type, 2019-2030 (USD Million)
6.1. Monoclonal Antibodies
6.2. Other Custom Antibodies
6.3. Polyclonal Antibodies
6.4. Recombinant Antibodies
7. Global Custom Antibody Market, By Service, 2019-2030 (USD Million)
7.1. Antibody Development
7.2. Antibody Production & Purification
7.3. Antibody Fragmentation & Labeling
8. Global Custom Antibody Market, By Source, 2019-2030 (USD Million)
8.1. Mice
8.2. Rabbits
8.3. Other Sources
9. Global Custom Antibody Market, By Research Area, 2019-2030 (USD Million)
9.1. Cardiovascular Disease
9.2. Immunology
9.3. Infectious Diseases
9.4. Neurobiology
9.5. Oncology
9.6. Other Research Areas
9.7. Stem Cells
10. Global Custom Antibody Market, By End-User, 2019-2030 (USD Million)
10.1. Academic & Research Institutes
10.2. Contract Research organizations
10.3. Pharmaceutical & Biotechnology Companies
11. Global Custom Antibody Market, By Region, 2019-2030 (USD Million)
11.1. North America
11.1.1. United States
11.1.2. Canada
11.1.3. Mexico
11.2. Europe
11.2.1. Germany
11.2.2. United Kingdom
11.2.3. France
11.2.4. Italy
11.2.5. Spain
11.2.6. Rest of Europe
11.3. Asia-Pacific
11.3.1. China
11.3.2. Japan
11.3.3. India
11.3.4. Australia
11.3.5. South Korea
11.3.6. Rest of Asia-Pacific
11.4. South America
11.4.1. Brazil
11.4.2. Argentina
11.4.3. Rest of South America
11.5. Middle East & Africa
11.5.1. Kingdom of Saudi Arabia
11.5.2. United Arab Emirates
11.5.3. Rest of Middle East & Africa
12. Company Profiles
12. 1. BioLegend
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. Bio-Rad Laboratories, Inc.
12.3. Cell Signaling Technology, Inc.
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. GenScript
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12. 5. Merck Group
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12. 6. Rockland Immunochemicals
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12. 7. Thermo Fisher Scientific, Inc
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments
12. Company Profiles
12. 1. BioLegend
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. Bio-Rad Laboratories, Inc.
12.3. Cell Signaling Technology, Inc.
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. GenScript
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12. 5. Merck Group
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12. 6. Rockland Immunochemicals
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12. 7. Thermo Fisher Scientific, Inc
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments
